DUSA Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference
February 08, 2012 08:30 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., Feb. 8, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT),...
DUSA Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference
February 06, 2012 09:10 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., Feb. 6, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT),...
DUSA Pharmaceuticals to Present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference
November 29, 2011 08:30 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., Nov. 29, 2011 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT) and...
DUSA Pharmaceuticals Reports Third Quarter 2011 Corporate Highlights and Financial Results
November 10, 2011 06:30 ET
|
DUSA Pharmaceuticals, Inc.
Domestic Kerastick® Revenues Increase 10% for the Quarter and 22% Year-to-Date; Quarterly BLU-U® Revenues Increase 54% Year-Over-Year
Conference Call and Audio Webcast Will be Held...
DUSA Pharmaceuticals, Inc.(R) to Host Third Quarter 2011 Corporate Highlights and Financial Results Webcast and Conference Call
November 03, 2011 06:30 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., Nov. 3, 2011 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc. (Nasdaq:DUSA) announces that its third quarter 2011 corporate highlights and financial results press release will be...
DUSA Pharmaceuticals, Inc.(R) to Exhibit at the AARP's Annual Life@50+ Conference
September 21, 2011 08:30 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., Sept. 21, 2011 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc. (Nasdaq:DUSA) announced today that it will be an official sponsor of and exhibitor at the AARP's Annual Life@50+...
DUSA Pharmaceuticals to Present at the Rodman & Renshaw 13th Annual Healthcare Conference
September 06, 2011 08:30 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., Sept. 6, 2011 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT) and...
DUSA Pharmaceuticals Reports Second Quarter 2011 Corporate Highlights and Financial Results
August 02, 2011 06:30 ET
|
DUSA Pharmaceuticals, Inc.
Quarterly Domestic Kerastick® Revenues Up 21% Year-Over-Year; Company Generates Significant Improvement in Cash Flow
Conference Call and Audio Webcast Will be Held Today, August 2nd, at 8:30...
DUSA Pharmaceuticals, Inc.(R) to Host Second Quarter 2011 Corporate Highlights and Financial Results Webcast and Conference Call
July 26, 2011 07:55 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., July 26, 2011 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc. (Nasdaq:DUSA) announces that its second quarter 2011 corporate highlights and financial results press release will be...
DUSA Pharmaceuticals, Inc.(R) Added to Russell 3000(R) Index
June 27, 2011 07:30 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., June 27, 2011 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT) and...